Hotcopper spl. ASX - Day TradingDoes Spl deserve to be seven times less in mkt cap to another biotech that has one phase 2 product spl potentially 3 and commercialisation deal with astra zeneca and collaboration deals with Merck and Genentech. Hotcopper spl

 
 ASX - Day TradingDoes Spl deserve to be seven times less in mkt cap to another biotech that has one phase 2 product spl potentially 3 and commercialisation deal with astra zeneca and collaboration deals with Merck and GenentechHotcopper spl  Right size, can penetrate deep into tumour tissue, right architecture, hang around long enough to do the job, soluble so the

Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. Join Australia’s largest community of ASX investors and share market enthusiasts in our free and independent stock market forum. Advertise on HotCopper. To be fair the ASX has made tries on 3 recent contracts to squeeze information from SPL when didn’t want to disclose how immaterial the contracts is. Do they actually work day in day out? Do research everyday? If so why after 20 years we are still at phase 1/2. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. With SPL we have entered a relatively short term period where things are going to develop into something serious. 00%. . Target our investor community with our suite of Hotcopper Advertising opportunities. 48. . . Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer. ASX - Day Trading. All along, SPL have said that they may sell off this entire arm of the business, or in fact once the Dep oncology advances further, perhsps split SPL into different businesses on the asx or to be sold off as completely separate businesses. There have been so many market sensitive announcements made and then ZEROfollow up on these announcements. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be. Join the HotCopper ASX share market forum today for free. Can anybody load up the most recent Bell Potter Analysis on SPL? I am unable to source it thanks. SPL could announce tomorrow that DEP doesn’t work and they’ll still find a way to spin it positively. Build your trading strategy and connect with. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. So SPL did the one thing they could to challenge the TGA they sent it to adjudication and TGA were told Feb 22 - you must accept application as medical device and SPL announced to ASX in April 22 that their application was in. )” ~@antibotter Jan 2019 (Hotcopper post #37005569) After ASX announcement ‘Positive DEP phase 2 interim results in prostate cancer’:Peak of the UK Flu season looks to have passed . FORTESCUE METALS GROUP LTD. 0¢ STARPHARMA HOLDINGS LIMITED - Discussion. Commodities. 9¢. Extract taken from recent interview with CEO of Starpharma Does it surprise you that big pharma hasn't come in and swooped in and bought the business to. ASX - By Stock. Disowned him really. 00 and $5. 13. All that seems to happen is that new verses are sometimes added. Remember that according to AZ’s own data, no patient had yet met the formal criteria of a response. 8¢. 55pm 17/11/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. 0 Created with. Created with Sketch. Last updated 15. Just to refresh people's memory I thought this summed by the exact situation with the TGA and Starpharm STARPHARMA’S COVID-KILLER NEEDS ACTION NOT. SPL Price at posting: 49. Then you have the obvious issues with distribution with Lloydsand possiblly really cheap deal with Vietnam let alone teh mysterious India ,. It must be great to ride the ASX executive remuneration gravy train like CEO Fairley has done for 18 years with Starpharma, and Chairman Rob Thomas has done for the majority of his long career. Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable. 0¢. Market . yet if one considers that the amount of millions of shares via option they. 14. To make matters worse he has AZD0466 on hold through no fault of the dendrimer technology, which appears to be highly successful in dealing with the drugs toxicity. . I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Created with Sketch. Canadian Dollar. 0834. 59pm 17/11/2023 ? HotCopper has news, discussion, prices and market data on SYRAH RESOURCES LIMITED. . Looking at the short term, SPL's SP is currently perched above a technical support line at 50 cents. Your post is very vague in its relationship somehow with spl, but the intent of the constant negative narrative is obvious. I was astounded to see that you Jackie were rewarded with a$200,000 bonus during this time. ASX - Day Trading. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 68. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. ASX - By Stock. 58pm 20/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Volume. Working in a. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . MGU Magnum Mining and Exploration piecing together optimal logistics plan for Buena Vista iron ore projectI don’t hold, but depending on timing with other investments and Starpharma developments I may become a SPL holder again if the SP drops another 10-20%. The recent announcement about Viraleze nasal spray going into production in Jan 2021, trying to hit the Euro markets in q1-q2 2021, caused a stir in the SP. Based on SPL's announcements and on reports of the AGM, my opinion is that the tune of the song that SPL sings never changes. Latest Posts. ASIC said Govinda faces a maximum penalty for each charge of 10 years’ prison, or a fine of up to $765,000, or both, after he entered the guilty pleas on Monday. SPL Price at posting: 14. A trader who used stock forum HotCopper to pump and dump about 20 penny stocks using 13 trading accounts has been given a jail term of 2½ years, but is being released immediately on a five-year. SPL Price at posting: 16. SPL scientists will no doubt be working on this right now. ASX - Day TradingAnyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. m. 26. Forums. You got to wonder after huge volumes going through last 4 days and the SP reaching new lows. The latest Hotcopper Holdings [HOT] news, articles, data and analysis from The Australian Financial Review About this app. Share Step 1. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. Created with Sketch. ASX - Short Term Trading. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. *talks with BIG multinational Company, should've already taken place with deals completed and signed soon after the trial. 19/09/23. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. m. . . Starpharma was 96 cents in April 2002. 166028. Join the HotCopper ASX share market forum today for free. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). The results will be good but will they be good enough for SPL to be able to do the deals. . “If humans respond in a similar way, the benefits of treatment. 8%. Come on SPL, complete these trials for the Companys sake, the shareholders sake and all the people out there suffering from these cancers. 362771. Unusual to make that announcement?. SPL Price at posting: $1. . 5¢ Sentiment: Sell Disclosure: Not HeldThe one positive sign is that AstraZeneca are continuing to expand site recruitment for both AZD0466 trials. Charts. Last edited by sarge17 : 19/09/20 SPL Price at posting: $1. . Market . We have oft heard the CEO brag about the $1B+ value of the AZD0466 milestones and license revenues. . AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. Feb 28 (Reuters) - Starpharma Holdings Ltd (SPL) : HY REVENUE FROM CONTINUING OPERATIONS DOWN 16% TO A$1. I am STILL inviting comment on SPL and their Zika proclamations, and how this is evidence of SPL’s long standing crumb throwing method. Forums. Join the HotCopper ASX share market forum today for free. This sort of action happens fairly often with SPL then followed by a pull back. . $-0. Just as I thought - both @antibotter and JF & Co. . On the subject of upfront licence fees Bell Potter in one of their analyses on SPL several years ago gave estimates of the likely upfront fees at $15M for Dep Doc, $8M for Dep Cab & $30M for Dep Irin. Created with Sketch. 74. I averaged down over the next year and the lowest point I bought was at 57c. most else of the list is same as we want to happen years ago and long long overdue. Our magic little formula may just be the answer. Just sayin'. Forums. Just begin to imagine that all staff on board use Viraleze well before. . SPL Ann: Application for quotation of securities - SPL SPL starpharma holdings limited Ann: Application for quotation of securities - SPL ASX News 851. 03% or subsequently a decrease in shorts of. RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. Forums. 1541401. 0¢. ASX - By Stock. 52 (16th Feb) on the back of the hype that surrounded the launch of VIRALEZE in UK/EU/WORLD. However, the interim results from ongoing Phase One NCT04865419 (the most advanced trial) was a little underwhelming IMO. I no longer regard SPL as an investment-grade stock. Pre-clinical results from a DEP HER2-Lutetium breast cancer model (see link below) were released by SPL in March 2021 with no update or published advancement since this announcement, and no deal/licence forthcoming. 72. 00. and even when Big pharma are challenged legally and lose in court as in Johnson and Johnson bladder slings - its 20 years after the tort, 8 yrs fighting in court to then be waiting waiting waiting for compensation not for pain and suffering in VICTORIA just inconvenience costs such as buying pads and pain killers. The goal of the partnership. Slow golf clap for Jackie Fairley. 53pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on SUNRISE ENERGY METALS LIMITED. it certainly is a confidence booster to keep on topping upGood luck with whatever investments you may hold at the moment, and if you’re still in SPL, hopefully it will get a bit of a bounce soon. 00%. Fortescue Metals Group Ltd (Fortescue) is an Australia-based company engaged in iron ore. great news but unlikely. HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Created with Sketch. I think that the more time that passes without profits, the less likely that there will ever be profits. Created with Sketch. it's a mess with multiple Substantial Holders dumping like this all while HQ remain. 16. Join the HotCopper ASX share market forum today for free. Meanwhile SPL seems to get into more schoolyard fights and then disagreements with Authority than company I have watched. We, as investors in this company deserve to knowmore. Forums. Labcorp Contacts: Media: Michele Mazur — 336-436-8263 Media@Labcorp. 0. Latest Posts. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . ASX - Day TradingGood to see another Aussie biotech who has been in communication with the FDA over the last 2 years since receiving a CRL have had their BLA resubmission accepted by the FDA. . 607432. SPL Price at posting: 71. July 31 (Reuters) - Starpharma Holdings Ltd (SPL) : ASTRAZENECA HAS MADE DECISION TO DISCONTINUE DEVELOPMENT OF AZD0466, AFTER AN INTERNAL REVIEW. ASX - By Stock. HotCopper has news,. 0. 0¢ Sentiment: None Disclosure: Not HeldHi FolksIts a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. I wonder if LLoyds are taking the pain on 50% off or if SPL rebating just to get volume and name in market ? LLoyds depending on agreemnet would usually just return stock IMO. Talk with one of our capital. SPL polylycine dendrimers are proving to play a major role in the future of ADC’s. I find it alarming the number of column inches in the resolution explanatory notes, extolling their experiences prior to spl, when not one of them has any achievements in the advancement of spl listed. Provide some keywords to assist in categorisation of your abstract. To me, that totally. ASX - Day Trading So the share price of SPL rose up to a high of $2. Share Great ad I think it will boom in Hong Kong under the Banitore Manning name, despite what the naysayers say Banitore have a big presence in China their manufacturing of health products is also in China I would imagine they have significant pull in China and other regions, In my opinion Viraleze is set to be a huge world product in tome. my apologies that I could not stay after the. Charts. 15667. 2. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Advertise on HotCopper. Created with Sketch. 1 Upvote. And it’s at least good to see that the ASX has demanded supplementary information from Starpharma on numerous occasions recently. 5. SPL. . Furthermore the shameful and disappointing thing is that some pumpers on this forum were encouraging newbies (even when the SP hit its $2. Created with Sketch. Forums. Even Pfizer won’t comment on him. Last updated 10. I have just sent. ASX - By Stock. ASX - Day TradingLast day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sellThe deal, which has an initial duration of 12 months, has the same terms as the previous agreement. . I think this is the start of a trail that may lead somewhere in hopefully SPL offering shareholder clearer explainations and referenced articles / posters etc in announcements being on website and then later being unavaliable is a process across the ASX that has to be stopped. . HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. m. Hope that SPL starts to deliver on its promises. . Application for quotation of securities - SPL. HotCopper is Australia's largest free and independent stock market trading forum for ASX investors to discuss share prices, the stock market and more. IMO they haven't . . Created with Sketch. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. 10 Year Chart looks like a rollercoaster:But the spike in volume over the past month suggests:a) We're near a huge breakoutORb) We're near a huge. Jackie Fairley says: “Clearly we are surprised and extremely disappointed. This is a charting thread for those interested in the movements of the SPL SP. StarPharma Holdings Ltd. 50 At this stage in the game, I would not accept anything under $5 (fact)Btw if Starpharma do receive an upfront milestone of $300 million for Dep Docetaxel, Dep Cabazitaxel and Dep Irinotecan license, I believe a special dividend will be paid out to all. 0012. 56am 20/11/2023 ? HotCopper has news, discussion, prices and market data on MAGNIS ENERGY TECHNOLOGIES LTD. . StarPharma Holdings Ltd. . Join the HotCopper ASX share market forum today for free. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . 8985. I can't guess where or what or when, perhaps there is an informed opinion out there in HC SPL land but we have a very tight market and some. Join the. ASX - By Stock. Share It would be silly to be tight on cash. ASX - General. Advertise on HotCopper. 36pm 23/11/2023 ? HotCopper has news, discussion, prices and market data on SPARC TECHNOLOGIES LIMITED. 1. ASX - By Stock. . 56. ASX - By Stock. Commodities. The 407730 is a sound level meter that measures from 40 to 130dB with an accuracy of 2dB. News: SPO Spotless Group To Be Removed From Official List Of ASX Ltd At Close Of Trading On 30 Aug. $0. AX8. You not understand how clinical trials works - it takes years to build regulatory packanage and do CMC. Notification of cessation of securities - SPL. 0¢. A correctly formatted example follows: Title of my presentation for the conference. This of course is on the back of long-serving lap dog and CFO/Secretary Nigel Baade resigning around the same time that the ASX asked Starpharma questions regarding continuous disclosure obligations and also whether a SPL announcement was tantamount to ramping. Last updated 10. Forums. SPL have hit road blocks with many of their products. Target our investor. ASX - General. Cristal therapeutics. Just to make sure we are all on the same page as far as AZD0466 is concerned The data available from the AACR SCLC Abstract (April 19th 2023) was from January 24th 2023 (it is out of date by more than 3 months)Fresh off the press 10th May 2023 The NHL trial is accelerating at a rapid rate Fyi 23 sites recruiting out 29 locations Since last update 8 additional. Some links within this article worth a scan too. Once they think they can get AZD0466 to market they will pounce if our share price is less tan $2. Is this a case of short memories? The best one can say is her surprise is disingenuous. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Don’t look to him for the truth lol. Market Cap $77. The Vancouver Island Wave program is the Island’s highest level of youth soccer participating in the BC Soccer Premier League. Created with Sketch. ASX - By Stock. 0. Join the HotCopper ASX share market forum today for free. Despite the length of time that SPL has been in existence, it is obvious that some players think that SPL is currently overvalued, hence the relentless selling. Join the HotCopper ASX share market forum today for free. ASX - Day TradingMelbourne, Australia; 6 May 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that VIRALEZE™ antiviral nasal spray is now available for purchase by consumers in Europe via Starpharma’s webstore. Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer model (BT474). Hey, "smart", I concur with your message. . Since then. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . This will make for sad reading. . Created with Sketch. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Viraleze being 1% less efficacious against the more potent dangerous new strains is an awesome result and should be celebrated. ASX - Day TradingCreated with Sketch. . 13. Become a member of Australia's largest investment discussion forum. We have oft heard the CEO brag about the $1B+ value of the AZD0466 milestones and license revenues. ASX - Short Term Trading. 0000. 22/9/2000 CSL $11. This extract caught my eye"The AstraZeneca programs involves $US124 million of milestones, about half of which are “relatively near”. I have just sent. Energy. Created with Sketch. Discussion. Join the HotCopper ASX share market forum today for free. , page-3. Search for Betafem BV, Fleurstat or Viraleze and you will often get competing products but no reference to what you searched for (that is the way Google works). 52pm 13/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. FDA, TGA, MHRA to pick fights and get knocked out and 2 blood noses. 70. I am closely watching the state of the World Economy, particularly China and the U. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. Created with Sketch. Last updated 15. Created with Sketch. Join Australia’s largest community of ASX investors and share market enthusiasts in our free and independent stock market forum. Last updated 15. Share Google Eddy Sunarto to read article about Starpharma stopping the next disease outbreak this is a great article about Viraleze the comments from CEO Jackie Fairley may suggest she is already aware of the results coming out of London imo. It is easy to be a negative poster on here when there has not been anything positive to come out of the company for a looooong time. . . 5. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. Last updated 15. 24am 31/10/2023 ? Share Prices & Charts for STARPHARMA HOLDINGS LIMITED. Advertise on HotCopper. Share lol @col69 the phrase "in parallel we are continuing discussions with potential commercial partners" is now etched into SPL's manual for any asx announcements or releases to the public. ASX - General. Not going to go over all the posts that are detailing what the spl7013 antiviral nasal spray may mean to the world others have done a great job. Surely, surely these great technical achievements will translate into commercial gains for the company and us long suffering SPL Shareholders. I will be unable to listen to the AGM but look forward to listening to the audio and reading Hotcopper comments and feed back after my afternoon shift. 199920. Pre-clinical results from a DEP HER2-Lutetium breast cancer model (see link below) were released by SPL in March 2021 with no update or published advancement since this announcement, and no. Market Cap $57. Market . That's how markets work sometimes. BCSPL – VI Wave. In SPL's case there is clearly another. Yes I think SPL does have a future but TIME is of the essence. S. 48. Market . 0%. Target our investor community with our suite of Hotcopper Advertising. ASX - By Stock. The recent announcement about Viraleze nasal. bc. There appears to be a different behavioural feel about. Merck will fund the research, although Starpharma doesn’t expect the fees to be material, and. SPL Price at posting: 44. They not even have a license with SPL, just a basic research agreement. 72. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Imo HotCopper posters must have an. ASX - By Stock. 00% 14. ASX - Day TradingI will just put it out there that I have been peeved off about our CEO Jackie Fairley and the performance of SPL for a while now. It’s unlikely to happen, but personally I hope Rob Thomas and Jackie Fairley fall on their sword prior to the AGM. 3¢. . 36. ASX - Day TradingTime to top up again for me What about youBetween Oct 2017 and Mar 2018 it seemed like we held pretty consistently above $1. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. SPL. 1dB. Click for. 0¢. ASX - By Stock. 26. . 3¢. ASX - Short Term Trading. 73. Last edited by sarge17: 28/11/22. I remember seeing a post on SPL had 41000 views. " Indeed. If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. HotCopper has news, discussion, prices and market data on SOUTHERN CROSS PAYMENTS LTD. 0¢ Sentiment: Hold Disclosure: Held Share Hi Folks Time to revisit the SPL Weekly chart. And somebody must be buying all the shares that are being sold. If they have poster data now it shoud be released to shareholders especially since they have used qualifying words such as good etc etc . SPL Price at posting. . Twelve month SPL daily chartSame old trend continues. HotCopper has news, discussion, prices and market data on SOUTHERN CROSS PAYMENTS LTD. International Markets. 129294. Created with Sketch. Some have been mentioned on this thread previously. any other information the entity wishes to notify to ASX about the cessation?The Performance Rights issued under an employee incentive scheme lapsed during the course of the quarter ended 30June 2023 include 519,053 Rights held by KMP, Nigel Baade, and 310,760 Rights held by non-KMPs. $0. ASX - General. . A correctly formatted example follows: Title of my presentation for the conference. Charts. Starpharma is a world leader in the development of new medical products based on its proprietary dendrimer technology and has partnerships with leading global companies, including AstraZeneca, MSD (Merck & Co. com Investors: Chas Cook — 336-436-5076 Investor@Labcorp. Views. .